G J Del Zoppo, H Zeumer, L A Harker. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute DiseaseCerebral Hemorrhage/chemically inducedCerebral Hemorrhage/complicationsCerebrovascular Disorders/drug therapyCerebrovascular Disorders/etiologyFibrinolytic Agents/administration & dosageFibrinolytic Agents/adverse effectsFibrinolytic Agents/therapeutic useHumansInfusions, Intra-ArterialInfusions, ParenteralIntracranial Embolism and Thrombosis/drug therapyIntracranial Embolism and Thrombosis/physiopathologyMyocardial Infarction/drug therapyPulmonary Embolism/drug therapyRiskThrombophlebitis/drug therapyThrombosis/drug therapy
Substances: See more » Fibrinolytic Agents
Year: 1986 PMID: 3526644 DOI: 10.1161/01.str.17.4.595
Source DB: PubMed Journal: Stroke ISSN: 0039-2499 Impact factor: 7.914